Nursing Notes

Monthly monitoring has arrived! FDA has approved monthly monitoring for clozapine patients who have experienced at least one year of acceptable WBC testing results. You can read all the details in the new FazaClo® (clozapine, USP) Orally Disintegrating Tablets package insert. Click here for full prescribing information. Another important difference is that going forward, all patients must have WBC and ANC test results available before each new prescription or refill.

Azur Pharma has been eagerly anticipating this milestone in FazaClo therapy and we are ready to help you transition your patients with as little confusion as possible. Need a quick refresher on ANCs? Click here to read more about ANCs.

We would like to update this column as often as possible. Please send your questions and ideas. Is there a good idea you would like to share with your colleagues? We’ll be glad to post it so that everyone can benefit. Remember, Azur Pharma provides 24-hour medical support related to FazaClo. Call us toll-free 877-FAZACLO (329-2256)…anytime.